Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02174406 · ClinicalTrials.gov registry record
Clinical Utility of Whole Breast Screening Ultrasound in Patients Undergoing Digital Breast Tomosynthesis
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 1,494
- Enrollment target
NCT02174406: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT02174406 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 1,494 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02174406 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 1,494 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether ultrasound or Digital breast tomosynthesis (DBT) detects more cancers and to compare the types of cancers detected on ultrasound and DBT.
Interventions
- PROCEDURE breast ultrasound
- PROCEDURE DBT (Full field digital mammography + tomosynthesis)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,494 participants |
| Start Date | 2014-06-23 |
| Est. Completion | 2023-01-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02174406
The ClinicalTrials.gov registry entry for NCT02174406 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,494 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which breast ultrasound is the first listed.
NCT02174406 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02174406 about?
NCT02174406 is a clinical study titled "Clinical Utility of Whole Breast Screening Ultrasound in Patients Undergoing Digital Breast Tomosynthesis". The purpose of this study is to determine whether ultrasound or Digital breast tomosynthesis (DBT) detects more cancers and to compare the types of cancers detected on ultrasound and DBT.
What is the current status of trial NCT02174406?
This trial is currently completed. The enrollment target is 1,494 participants. The study started on 2014-06-23. Estimated completion is 2023-01-19.
What interventions are being tested in trial NCT02174406?
The interventions under investigation include: breast ultrasound (PROCEDURE), DBT (Full field digital mammography + tomosynthesis) (PROCEDURE).
Who is sponsoring clinical trial NCT02174406?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.